Quality of life in Italian patients with Multiple endocrine neoplasia type 1 (MEN 1): results of an extensive survey.
HADS
IES-R
LOT-R
Multiple endocrine neoplasia type 1
Neuroendocrine tumors
Quality of life
SF-36
Journal
Orphanet journal of rare diseases
ISSN: 1750-1172
Titre abrégé: Orphanet J Rare Dis
Pays: England
ID NLM: 101266602
Informations de publication
Date de publication:
06 01 2021
06 01 2021
Historique:
received:
08
10
2020
accepted:
17
12
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
22
6
2021
Statut:
epublish
Résumé
MEN1 is a complex, rare, syndrome inherited in an autosomal dominant tract and characterized by the development of multiple neuroendocrine tumors, requiring lifelong surveillance and multiple medical and surgical therapies throughout the patient's life. For all these reasons, a diagnosis of MEN1 can be a psychological shock for the patient, as well as his/her relatives, more so than the diagnosis of a single tumor. In the last two decades, clinicians have started to consider the emotional, psychological, relational, and social aspects of their patients' lives. The data collected in the present analyses highlight the unique features of MEN1 syndrome, and aim to evaluate the Quality of Life in the patients and their relatives. In this study, a comprehensive survey of various aspects of Health-Related Quality of Life was performed in a large series of Italian MEN1 patients, by administering five of the most common targeted questionnaires. The results of the study showed that our patients, despite having a complex multi-tumor syndrome, were moderately optimistic (50%), and this corresponds with a normal Quality of Life. This positive response is strictly correlated with the fact that the patients are cared for at a dedicated Referral Center, receiving personalized care and constant follow-up, which gives them reassurance regarding the high quality of management of the disorder. The possibility of having access to a clinical Referral Center for their complex rare disease, together with the support of a dedicated patient association, has been demonstrated to be the ideal model for the management of post-diagnosis shock, and contributes to the preservation of a good Health-Related Quality of Life for MEN1 patients.
Sections du résumé
BACKGROUND
MEN1 is a complex, rare, syndrome inherited in an autosomal dominant tract and characterized by the development of multiple neuroendocrine tumors, requiring lifelong surveillance and multiple medical and surgical therapies throughout the patient's life. For all these reasons, a diagnosis of MEN1 can be a psychological shock for the patient, as well as his/her relatives, more so than the diagnosis of a single tumor. In the last two decades, clinicians have started to consider the emotional, psychological, relational, and social aspects of their patients' lives. The data collected in the present analyses highlight the unique features of MEN1 syndrome, and aim to evaluate the Quality of Life in the patients and their relatives. In this study, a comprehensive survey of various aspects of Health-Related Quality of Life was performed in a large series of Italian MEN1 patients, by administering five of the most common targeted questionnaires.
RESULTS
The results of the study showed that our patients, despite having a complex multi-tumor syndrome, were moderately optimistic (50%), and this corresponds with a normal Quality of Life. This positive response is strictly correlated with the fact that the patients are cared for at a dedicated Referral Center, receiving personalized care and constant follow-up, which gives them reassurance regarding the high quality of management of the disorder.
CONCLUSIONS
The possibility of having access to a clinical Referral Center for their complex rare disease, together with the support of a dedicated patient association, has been demonstrated to be the ideal model for the management of post-diagnosis shock, and contributes to the preservation of a good Health-Related Quality of Life for MEN1 patients.
Identifiants
pubmed: 33407684
doi: 10.1186/s13023-020-01650-y
pii: 10.1186/s13023-020-01650-y
pmc: PMC7788910
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16Références
Int J Clin Health Psychol. 2017 May-Aug;17(2):161-170
pubmed: 30487891
Surgery. 2018 Jan;163(1):205-211
pubmed: 29128174
J Clin Endocrinol Metab. 2012 Sep;97(9):2990-3011
pubmed: 22723327
J Clin Epidemiol. 1998 Nov;51(11):1025-36
pubmed: 9817120
Behav Res Ther. 2003 Dec;41(12):1489-96
pubmed: 14705607
Clin Adv Hematol Oncol. 2016 Dec;14(12):999-1009
pubmed: 28212362
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Soc Sci Med. 1995 Nov;41(10):1403-9
pubmed: 8560308
J Clin Epidemiol. 1998 Nov;51(11):1203-14
pubmed: 9817138
Fam Cancer. 2003;2(1):27-33
pubmed: 14574164
J Clin Endocrinol Metab. 2018 Jun 1;103(6):2354-2361
pubmed: 29618015
Ann Oncol. 2011 Oct;22(10):2330-3
pubmed: 21339383
J Genet Couns. 2007 Feb;16(1):105-17
pubmed: 17277996
Orphanet J Rare Dis. 2018 Nov 14;13(1):205
pubmed: 30428914